Showing 321-330 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Ketone Monitoring in T1D: Effect of SGLT2i during Usual Care and with Insulin Deficiency | Washington University | Janet McGill | Improving Lives | 01-September-2022 to 31-August-2024 | $359,651.69 |
| Orally Delivered Glucose-Responsive Insulin | Wayne State University | Zhiqiang Cao | Improving Lives | 01-June-2024 to 31-May-2026 | $274,499.13 |
| Immune tolerance technology for islet transplantation | Wayne State University | Zhiqiang Cao | Cures | 01-July-2023 to 30-June-2025 | $199,231.00 |
| Co-transplantation of adaptive human endothelium and islets within encapsulated angiogenic hydrogels for durable engraftment | Weill Medical College of Cornell University | Shahin Rafii | Cures | 01-December-2023 to 30-November-2026 | $1,000,000.00 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600,000.00 |
| Spatial and temporal regulation of proangiogenic factors to support islet cell transplantation | William Marsh Rice University | Omid Veiseh | Cures | 01-January-2025 to 31-December-2027 | $900,000.00 |
| Localized immune modulation to enable long-term beta cell survival | William Marsh Rice University | Omid Veiseh | Cures | 01-September-2022 to 31-August-2025 | $600,000.00 |
| Understanding Role of B cells in the pathogenesis of Type 1 Diabetes and Multiple Sclerosis | Yale University | Yoshiaki Yasumizu | Cures | 01-September-2025 to 31-August-2026 | $149,191.66 |
| Engineering inflammation resistant beta cells | Yale University | Kevan Herold | Cures | 01-September-2023 to 31-August-2025 | $499,999.37 |
| Combination of anti-CD3 mAb and antigen specific nanoparticles for prevention and treatment of Type 1 diabetes | Yale University | Kevan Herold | Cures | 01-June-2022 to 30-April-2025 | $600,000.00 |